Key Points
- CEO John Kao sold 180,000 shares on Dec. 10 at an average price of $19.02 for about $3.42 million, trimming his holding by 7.12% to 2,346,726 shares.
- Alignment beat the recent quarter's estimates with $0.02 EPS (vs. -$0.01 est.) and $993.7M revenue (up 43.5% YoY), but still posts a negative net margin (-0.57%) and negative ROE (-16.23%).
- The stock trades near $19 with a $3.87B market cap and a consensus rating of “Moderate Buy” (average price target $20.05), while institutional investors own about 86.19% of the shares.
Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) COO Sebastian Burzacchi sold 12,585 shares of the stock in a transaction dated Wednesday, December 10th. The shares were sold at an average price of $19.26, for a total transaction of $242,387.10. Following the completion of the sale, the chief operating officer owned 237,793 shares of the company's stock, valued at approximately $4,579,893.18. The trade was a 5.03% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Alignment Healthcare Trading Down 0.3%
Shares of ALHC opened at $19.36 on Friday. The stock's 50-day moving average price is $17.65 and its 200 day moving average price is $15.82. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 1.99. The firm has a market capitalization of $3.87 billion, a price-to-earnings ratio of -161.33 and a beta of 1.16. Alignment Healthcare, Inc. has a 12-month low of $10.18 and a 12-month high of $21.06.
Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings data on Thursday, October 30th. The company reported $0.02 earnings per share for the quarter, topping the consensus estimate of ($0.01) by $0.03. The company had revenue of $993.70 million for the quarter, compared to analyst estimates of $980.90 million. Alignment Healthcare had a negative return on equity of 16.23% and a negative net margin of 0.57%.Alignment Healthcare's revenue for the quarter was up 43.5% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.14) EPS. As a group, research analysts predict that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.
Wall Street Analysts Forecast Growth
Several equities research analysts have issued reports on the stock. JPMorgan Chase & Co. raised shares of Alignment Healthcare from a "neutral" rating to an "overweight" rating and boosted their price target for the company from $18.00 to $20.00 in a report on Monday, November 24th. Zacks Research lowered shares of Alignment Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, October 28th. KeyCorp reissued an "overweight" rating on shares of Alignment Healthcare in a research report on Monday, November 24th. UBS Group lifted their price objective on Alignment Healthcare from $17.00 to $18.00 and gave the company a "neutral" rating in a report on Friday, October 31st. Finally, Wall Street Zen raised Alignment Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, November 8th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Alignment Healthcare presently has an average rating of "Moderate Buy" and an average price target of $20.05.
Read Our Latest Stock Analysis on ALHC
Hedge Funds Weigh In On Alignment Healthcare
Several institutional investors have recently bought and sold shares of the business. Raymond James Financial Inc. increased its position in Alignment Healthcare by 31.1% in the first quarter. Raymond James Financial Inc. now owns 206,174 shares of the company's stock worth $3,839,000 after purchasing an additional 48,901 shares during the period. Strs Ohio bought a new stake in shares of Alignment Healthcare in the 1st quarter valued at $600,000. Ameritas Investment Partners Inc. raised its position in shares of Alignment Healthcare by 32.9% during the second quarter. Ameritas Investment Partners Inc. now owns 13,031 shares of the company's stock worth $182,000 after purchasing an additional 3,225 shares during the period. Acadian Asset Management LLC lifted its stake in Alignment Healthcare by 1,025.2% in the first quarter. Acadian Asset Management LLC now owns 375,949 shares of the company's stock valued at $6,992,000 after buying an additional 342,537 shares in the last quarter. Finally, Adage Capital Partners GP L.L.C. increased its holdings in Alignment Healthcare by 101.5% during the 1st quarter. Adage Capital Partners GP L.L.C. now owns 69,497 shares of the company's stock worth $1,294,000 after purchasing an additional 35,000 shares in the last quarter. Institutional investors own 86.19% of the company's stock.
Alignment Healthcare Company Profile
(
Get Free Report)
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
